Skip to content

Clinical trials

Phase 1 Leukemia, Erythroblastic, Acute trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Erythroblastic, Acute Phase: Phase 1 Clear all

48 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20023
20032
20046
200510
20062
20073
20081
20091
20104
20111
20122
20133
20142
20151
20161

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed36
Terminated11
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)17
Case Comprehensive Cancer Center4
Roswell Park Cancer Institute4
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins3
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University2
Bruno C. Medeiros1
Daiichi Sankyo1
Gruppo Italiano Malattie EMatologiche dell'Adulto1
M.D. Anderson Cancer Center1
Memorial Sloan Kettering Cancer Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Erythroblastic, Acute48
Leukemia, Myeloid, Acute48
Leukemia, Megakaryoblastic, Acute46
Leukemia, Monocytic, Acute46
Leukemia, Myelomonocytic, Acute45
Congenital Abnormalities35
Precursor Cell Lymphoblastic Leukemia-Lymphoma22
Leukemia, Basophilic, Acute21
Leukemia, Eosinophilic, Acute21
Leukemia20

Trials

Showing 76 to 48 of 48. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.